Top 10 Telmisartan (Micardis) Generic Manufacturers in India

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

In recent years, the pharmaceutical industry in India has seen significant growth in the production of generic drugs, including Telmisartan, which is commonly marketed under the brand name Micardis. With a growing demand for affordable medications, Indian manufacturers have become key players in the global market. According to recent data, India is the largest supplier of generic drugs globally, accounting for over 20% of global exports.

Top 10 Telmisartan (Micardis) Generic Manufacturers in India:

1. Sun Pharmaceutical Industries Ltd.
With an annual production volume of over 500 metric tons, Sun Pharmaceutical Industries Ltd. is one of the leading manufacturers of Telmisartan generics in India. The company holds a significant market share both domestically and internationally.

2. Lupin Limited
Lupin Limited is another major player in the Telmisartan generics market, with a production volume exceeding 400 metric tons per year. The company’s high-quality products have gained popularity among healthcare professionals and patients alike.

3. Cipla Limited
Cipla Limited is known for its wide range of pharmaceutical products, including Telmisartan generics. With a strong presence in both domestic and international markets, the company has established itself as a reliable supplier of affordable medications.

4. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is a well-known name in the pharmaceutical industry, producing over 300 metric tons of Telmisartan generics annually. The company’s commitment to research and development has contributed to its success in the market.

5. Aurobindo Pharma Limited
Aurobindo Pharma Limited is a leading manufacturer of Telmisartan generics in India, with a production volume of over 250 metric tons per year. The company’s focus on innovation and quality has helped it gain a competitive edge in the market.

6. Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. has a strong presence in the Telmisartan generics market, with an annual production volume of over 200 metric tons. The company’s emphasis on customer satisfaction and product quality has made it a preferred choice among healthcare providers.

7. Zydus Cadila
Zydus Cadila is a prominent player in the pharmaceutical industry, producing over 150 metric tons of Telmisartan generics each year. The company’s commitment to sustainability and ethical business practices has earned it a favorable reputation in the market.

8. Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. is known for its diverse product portfolio, including Telmisartan generics. With an annual production volume of over 100 metric tons, the company has established itself as a reliable supplier of high-quality medications.

9. Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. has a strong presence in the Telmisartan generics market, with a production volume exceeding 80 metric tons per year. The company’s focus on research and development has enabled it to introduce innovative products to meet the needs of patients worldwide.

10. Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd. is a key player in the Telmisartan generics market, producing over 50 metric tons annually. The company’s commitment to quality and affordability has helped it gain a competitive edge in the industry.

Insights:

The market for Telmisartan generics in India is expected to continue growing in the coming years, driven by factors such as increasing healthcare expenditure and a rising prevalence of chronic diseases. According to industry forecasts, the market size for Telmisartan generics in India is projected to reach $X billion by 2025, with a CAGR of X%.

As Indian manufacturers continue to focus on innovation and quality, they are likely to capture a larger share of the global market for generic drugs. With a strong manufacturing base and a skilled workforce, India is well-positioned to maintain its leading position in the production of Telmisartan generics. As competition in the industry intensifies, companies will need to differentiate themselves through product quality, pricing strategies, and customer service to stay ahead in the market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →